Pericoital Oral LNG
Description: Levonorgestrel (LNG) 0.75 mg tablets
Product Details
Dose: 0.75 mg
Active Pharmaceutical Ingredient (API):
Status Details
Developer: , ,
Additional Information
References: Taylor DJ, et al. (2014) A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel. Contraception. 89(3):215-21.
PATH website: https://www.path.org/resources/womens-self-care-products-and-practices/
Clinicaltrials.gov Identified NCT00922233
Taylor DJ, et al. (2014) A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel. Contraception. 89(3):215-21.
PATH website: https://www.path.org/resources/womens-self-care-products-and-practices/
Clinicaltrials.gov Identified NCT00922233